These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16563889)

  • 1. Effect of intentional infliximab use throughout pregnancy in inducing and maintaining remission in Crohn's disease.
    Tursi A
    Dig Liver Dis; 2006 Jun; 38(6):439-40. PubMed ID: 16563889
    [No Abstract]   [Full Text] [Related]  

  • 2. [Infliximab in the treatment of Crohn's disease -- a practical approach. Infliximab and chronic Crohn's disease--Consensus statement of the Working Group on Chronic Inflammatory Crohn's Diseases of the OGGH].
    Tilg H; Knoflach P; Petritsch W; Vogelsang H; Reinisch W;
    Z Gastroenterol; 2004 Oct; 42(10):1256-63. PubMed ID: 15508068
    [No Abstract]   [Full Text] [Related]  

  • 3. How deep is remission in perianal Crohn's disease and do imaging modalities matter?
    Savoye G; Savoye-Collet C
    Am J Gastroenterol; 2010 Jun; 105(6):1445-6; author reply 1446. PubMed ID: 20523317
    [No Abstract]   [Full Text] [Related]  

  • 4. Short-term study of infliximab treatment for Crohn's disease in China.
    Zheng JJ; Zhi P; Wang YM; Zhu F; Gu W; Xing YC; Zhou CL; Shen BW
    J Dig Dis; 2011 Apr; 12(2):105-9. PubMed ID: 21401895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic vulval Crohn's disease and infliximab: a case report.
    Tritton SM; Whyte L; Fischer G
    J Reprod Med; 2009 Jan; 54(1):41-4. PubMed ID: 19263879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-alpha antagonists: benefits beyond remission.
    Mahadevan U
    Rev Gastroenterol Disord; 2007; 7 Suppl 1():S13-9. PubMed ID: 17392633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab use in luminal Crohn's disease.
    Richter JA; Bickston SJ
    Gastroenterol Clin North Am; 2006 Dec; 35(4):775-93. PubMed ID: 17129813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous metastatic Crohn's disease responsive to infliximab.
    Petrolati A; Altavilla N; Cipolla R; Fenderico P; Forlini G; Nasoni S; Rossi Z
    Am J Gastroenterol; 2009 Apr; 104(4):1058. PubMed ID: 19259072
    [No Abstract]   [Full Text] [Related]  

  • 9. Usefulness of an elemental diet in Crohn's disease.
    Takahashi H; Ando T; Watanabe O; Maeda O; Ishiguro K; Ohmiya N; Niwa Y; Goto H
    Inflammopharmacology; 2007 Feb; 15(1):15-7. PubMed ID: 17323189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infliximab-induced pustular psoriasis in a patient with Crohn's disease].
    Monteagudo Sánchez B; Cabanillas M; Ortiz-Marin S; Gallego-Ojea JC
    Gastroenterol Hepatol; 2009 Mar; 32(3):175-6. PubMed ID: 19233516
    [No Abstract]   [Full Text] [Related]  

  • 11. Infliximab therapy in children with Crohn's disease: a one-year evaluation of efficacy comparing 'top-down' and 'step-up' strategies.
    Kim MJ; Lee JS; Lee JH; Kim JY; Choe YH
    Acta Paediatr; 2011 Mar; 100(3):451-5. PubMed ID: 20626362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease.
    Maser EA; Villela R; Silverberg MS; Greenberg GR
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1248-54. PubMed ID: 16931170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of recurrent Crohn's uveitis with infliximab.
    Ally MR; Veerappan GR; Koff JM
    Am J Gastroenterol; 2008 Aug; 103(8):2150-1. PubMed ID: 18796120
    [No Abstract]   [Full Text] [Related]  

  • 14. Palmoplantar pustulosis and acrodermatitis in a patient treated with infliximab for Crohn's sacroiliitis.
    Wermuth J; Kind F; Steuerwald M
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):A28. PubMed ID: 19187898
    [No Abstract]   [Full Text] [Related]  

  • 15. What is the rate of loss of response to infliximab therapy in Crohn's disease?
    Chao J; Mulani P
    Am J Gastroenterol; 2009 Sep; 104(9):2353-4; author reply 2354-5. PubMed ID: 19727093
    [No Abstract]   [Full Text] [Related]  

  • 16. Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery.
    Kane S; Ford J; Cohen R; Wagner C
    J Clin Gastroenterol; 2009 Aug; 43(7):613-6. PubMed ID: 19142167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orofacial granulomatosis as first manifestation of Crohn's disease: successful treatment of both conditions with a combination of infliximab and dapsone.
    Kemmler N; Pfannschmidt N; Strohal R
    Acta Derm Venereol; 2012 Jul; 92(4):406-7. PubMed ID: 22113308
    [No Abstract]   [Full Text] [Related]  

  • 18. The management of fistulizing oral Crohn's disease with infliximab.
    Staines KS; Green R; Felix DH
    J Oral Pathol Med; 2007 Aug; 36(7):444-6. PubMed ID: 17617840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic therapy in Crohn's disease: review of the evidence.
    Loftus EV
    Rev Gastroenterol Disord; 2007; 7 Suppl 1():S3-12. PubMed ID: 17392631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of medically induced remission of Crohn's disease.
    Gonvers JJ; Juillerat P; Mottet C; Pittet V; Felley C; Vader JP; Michetti P; Froehlich F
    Digestion; 2007; 76(2):116-29. PubMed ID: 18239403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.